Incyte (INCY) Shares Outstanding (Entity) (2010 - 2026)

Incyte (INCY) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 200.18 Mn
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn 199.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 199.95 Mn
Dec 31, 2025 198.46 Mn
Sep 30, 2025 196.13 Mn
Jun 30, 2025 194.12 Mn
Mar 31, 2025 193.78 Mn
Dec 31, 2024 193.43 Mn
Sep 30, 2024 192.80 Mn
Jun 30, 2024 191.57 Mn
Mar 31, 2024 224.53 Mn
Dec 31, 2023 224.29 Mn
Sep 30, 2023 224.10 Mn
Jun 30, 2023 223.34 Mn
Mar 31, 2023 223.06 Mn
Dec 31, 2022 222.75 Mn
Sep 30, 2022 222.45 Mn
Jun 30, 2022 221.88 Mn
Mar 31, 2022 221.41 Mn
Dec 31, 2021 221.08 Mn
Sep 30, 2021 220.89 Mn
Jun 30, 2021 220.42 Mn